Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Breast Cancer Res Treat. 2018 Mar 9;170(2):293–302. doi: 10.1007/s10549-018-4745-7

Table 2.

Recurrence free survival and overall survival correlation with PD-L1 and stromal tumor infiltrating lymphocytes

	Recurrence Free Survival				Overall Survival
	Overall	Recurrence	No recurrence	p-value	Overall	Death	No death	p-value
	(n=182)	(n=30)	(n=152)	p-value	(n=191)	(n=20)	(n=171)	p-value
TIL-Str	25 (0-85)	16 (0-50)	25 (0-85)	0.101	24 (0-85)	6 (3-85)	25 (0-80)	0.005
28-8 in tumor	1.2 (0-85)	0 (0-11.7)	1.7 (0-85)	0.055	1.2 (0-85)	2.3 (0-66.7)	0.8 (0-85)	0.618
28-8 in TILs	4.2 (0-91.7)	0 (0-26.7)	5 (0-91.7)	0.011	4 (0-91.7)	1 (0-60)	5 (0-91.7)	0.300
22C3 in tumor	0 (0-73.3)	0 (0-0.8)	0 (0-73.3)	0.149	0 (0-73.3)	0 (0-51.7)	0 (0-73.3)	0.388
22C3 in TILs	0.8 (0-66.7)	0 (0-27)	0.8 (0-66.7)	0.566	0.8 (0-66.7)	0 (0-61.7)	0.8 (0-66.7)	0.140